Member Info for Wiggly

I think we are creating issues out of nothing, not helped by the sly derampers WYN and NDN.

It is April 13th and while frustrating that we are still waiting (even more frustrating considering Ive been waiting since last summer!), every passing hour brings us closer to the Big RNS - unlike last Summer, we are in active CV, and very likely near completion... We are still +/- 'around the end of Q1' and with results scheduled for April 22nd, I am sure that AS and team now have sufficient data on hand to feel 100% confident that CV will be concluded by April 22nd, hence release of todays RNS.

Ridiculous question.

Is going to be rather exciting! I certainly do not wish to be out this weekend!

The odds on an RNS early next week is very high and I think todays strength speaks volumes about what is coming our way!

Yes, it is very exciting. Dropping £400k at the ATH strikes me as more than just confidence!

09-Apr-21 11:21:30 275.00 70,000 Buy* 273.00 275.00 192.50k O ?

09-Apr-21 11:21:30 275.00 70,000 Buy* 273.00 275.00 192.50k O

Call the plumber we have a LEEEAAKK!!!

I am calling a leak!

Today could be very interesting!

Is Bojo speaking about testing later today?

Is today the day that the UK Gov will announce their Sovereign test?

Could be time!

Have not yet announced their sovereign test and still no orders placed with GAD and ODX? So I assume the test of choice is not yet ready. but must be close considering the Gov plans to test the UK population twice weekly starting end of this month.

It surely cannot be a coincidence that the actions from the UK gov are perfectly timed with the AVCT LFT validation? If there was doubt as to how the CV was progression, I think they would have implemented their back up option by now (assuming they have one).

Still unable to buy or sell with Interactive investor

Still unable to buy 1 share at 265.

Whats going on?

RNS incoming?

Cant buy or sell - about to blow!

Good post from PMH on twitter, which makes 100% sense.

'If I was a betting man - ie given the distribution agreement with ABCAM yesterday (re Elisa - High Sensitivity and Excellent Specificity) - then AVCT Affimer reagent chemistry clearly works well.

Hence, Assuming the mechanics of the RLFT have been similarly designed & manufactured, then it wouldn't take too much imagination to presume the final results from the CV & CE marking - would equally be in line with what was indicated previously'

I would add to the above..

The team have worked for over 1 year to perfect the LFT and would not be progressing with the full CV if there was any doubt whatsoever that it would disappoint.

AS has addressed all risk upfront (as mentioned multiple times) to ensure the LFT is a major success.

Sujood has always intimated that he is on the inside. ….

Why else is AS focusing on LFT instead of BAMS?

He is focussing on the LFT as it is going to $ billions

Why else is AS focusing on LFT instead of BAMS?

LOLOL!!!

BAMS did not fail. It was being validated via an alternative route!

TWAT

260s incoming.

Call the plumber, quick!

It is a fantastic thing to partner with ABCAM and proves very much that the Affimer is a quality product!

In addition, lets not underestimate the following;

"We are delighted that we have established a global route to market for the SARS-CoV-2 spike protein Affimer® reagents through ABCAM's dedicated global commercialisation infrastructure.

Why did the above not read as follows;

"We are delighted that we have established a global route to market for the SARS-CoV-2 ELISA spike protein Affimer® reagents through ABCAM's dedicated global commercialisation infrastructure.